FDA Approvals Bring New Hope for Patients With BRCA-mutant Ovarian Cancer
Just before the holidays, the U.S. Food and Drug Administration (FDA) had good news for the ovarian cancer research...
Just before the holidays, the U.S. Food and Drug Administration (FDA) had good news for the ovarian cancer research...
Last week, more than 100 patients, survivors, family members, advocates, and researchers came together for a symposium at the...
In the coming months, we will share posts from advocates who participated in the AACR’s Scientist↔Survivor Program at the...